Morgan Stanley
LUCD icon

Morgan Stanley’s Lucid Diagnostics LUCD Stock Holding History

Morgan Stanley’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.3K Buy
65,743
+19,706
+43% +$21.2K ﹤0.01% 6382
2026
Q1 		$52.9K Sell
46,037
-56,561
-55% -$72K ﹤0.01% 6404
2025
Q4 		$112K Buy
102,598
+4,899
+5% +$5.48K ﹤0.01% 6141
2025
Q3 		$98.7K Sell
97,699
-368,931
-79% -$403K ﹤0.01% 6157
2025
Q2 		$537K Buy
466,630
+355,040
+318% +$459K ﹤0.01% 5433
2025
Q1 		$166K Buy
111,590
+56,996
+104% +$68.4K ﹤0.01% 5812
2024
Q4 		$44.7K Buy
54,594
+54,200
+13,756% +$47.8K ﹤0.01% 6319
2024
Q3 		$321 Sell
394
-560
-59% -$459 ﹤0.01% 7346
2024
Q2 		$782 Sell
954
-22
-2% -$19 ﹤0.01% 7183
2024
Q1 		$790 Buy
976
+776
+388% +$1.01K ﹤0.01% 7197
2023
Q4 		$282 Hold
200
– – ﹤0.01% 7269
2023
Q3 		$234 Hold
200
– – ﹤0.01% 7373
2023
Q2 		$278 Sell
200
-600
-75% -$904 ﹤0.01% 7425
2023
Q1 		$1.12K Sell
800
-93
-10% -$129 ﹤0.01% 7337
2022
Q4 		$1.21K Sell
893
-18,361
-95% -$33K ﹤0.01% 7443
2022
Q3 		$30K Sell
19,254
-39,092
-67% -$97.3K ﹤0.01% 6621
2022
Q2 		$131K Buy
58,346
+49,117
+532% +$109K ﹤0.01% 6129
2022
Q1 		$31K Sell
9,229
-12,533
-58% -$45.8K ﹤0.01% 6937
2021
Q4 		$116K Buy
+21,762
New +$177K ﹤0.01% 6352

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley's LUCD Position: Q2 2026 in Review

Morgan Stanley increased its Lucid Diagnostics (LUCD) stake by 43% in Q2 2026, buying an estimated $21.2K and bringing the position to 65,743 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6382.

Morgan Stanley first reported a position in LUCD in Q4 2021 and has held it in 19 quarters since. The position peaked at $537K in Q2 2025. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Morgan Stanley held 65,743 shares of Lucid Diagnostics worth $70.3K as of Q2 2026.
  • Morgan Stanley bought 19,706 Lucid Diagnostics shares in Q2 2026, an estimated $21.2K.
  • Lucid Diagnostics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6382 holding.
  • Morgan Stanley first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • Morgan Stanley's Lucid Diagnostics position peaked at $537K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.